Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Services claiming to be JNM are soliciting authors, editors, and reviewers. Read more to protect yourself.

  • CD70-Targeted [18F]RCCB6 Immuno-PET/CT Imaging in Patients with Nasopharyngeal Carcinoma: A Proof-of-Concept Study
  • Targeting Extra Domain A of Fibronectin to Improve Noninvasive Detection of Triple-Negative Breast Cancer
  • Listen to the JNM Podcast, now available wherever you get your podcasts.
  • Entities are misrepresenting themselves as JNM. Read more on how to protect yourself.
  • 1
  • 2
  • 3
  • 4

Published Ahead of Print

  • Whole-Body [<sup>18</sup>F]DPA-714 Kinetic Assessment Using PET/CT Scanner with Long Axial Field of View
    You have access
    Whole-Body [18F]DPA-714 Kinetic Assessment Using PET/CT Scanner with Long Axial Field of View
    Xavier Palard-Novello, Denise Visser, Maqsood Yaqub, Elsmarieke van de Giessen, Marijke E. den Hollander, Albert D. Windhorst, Sander C.J. Verfaillie, Hans Knoop, Bart N.M. van Berckel, Sandeep S.V. Golla, Nelleke Tolboom and Ronald Boellaard
    Journal of Nuclear Medicine May 29, 2025, jnumed.124.268979; DOI: https://doi.org/10.2967/jnumed.124.268979
  • [<sup>18</sup>F]FDG PET/CT Predicts Patient Survival in Patients with Systemic Sclerosis–Associated Interstitial Lung Disease
    Open Access
    [18F]FDG PET/CT Predicts Patient Survival in Patients with Systemic Sclerosis–Associated Interstitial Lung Disease
    David M.L. Lilburn, Helen S. Garthwaite, Balaji Ganeshan, Thida Win, Nicholas J. Screaton, Luke R. Hoy, Darren Walls, Raymond Endozo, Robert I. Shortman, Francesco Fraioli, Athol U. Wells, Christopher P. Denton, Ashley M. Groves and Joanna C. Porter
    Journal of Nuclear Medicine May 29, 2025, jnumed.125.269497; DOI: https://doi.org/10.2967/jnumed.125.269497
  • Granzyme B PET Imaging Predicts Response to Immunotherapy in a Diet-Induced Obesity Model of Breast Cancer
    Open Access
    Granzyme B PET Imaging Predicts Response to Immunotherapy in a Diet-Induced Obesity Model of Breast Cancer
    Shannon E. Lynch, Corinne Crawford, Addison L. Hunt, Luke L. Sligh, Yujun Zhang, Lyse A. Norian, Benjamin M. Larimer, Suzanne E. Lapi and Anna G. Sorace
    Journal of Nuclear Medicine May 29, 2025, jnumed.124.268938; DOI: https://doi.org/10.2967/jnumed.124.268938
  • Clinical Outcomes of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience
    You have access
    Clinical Outcomes of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience
    Kunal Ramesh Chandekar, Swayamjeet Satapathy, Sanjana Ballal, Madhav Prasad Yadav, Shubha Gadde Ravindra, Sameer Rastogi, Ranjit Kumar Sahoo and Chandrasekhar Bal
    Journal of Nuclear Medicine May 29, 2025, jnumed.125.269456; DOI: https://doi.org/10.2967/jnumed.125.269456
  • You have access
    Rethinking Dosimetry: A European Perspective
    Johannes Tran-Gia, Francesco Cicone, Michel Koole, Francesco Giammarile, Jonathan Gear, Emmanuel Deshayes, Pablo Minguez Gabiña, Marta Cremonesi, Jonathan Wadsley, Peter Bernhardt, Manuel Bardiès, Silvano Gnesin, Mattias Sandström, Ulrike Garske-Román, Mona-Elisabeth R. Revheim, Frederik A. Verburg, Mark Konijnenberg, Bernd Joachim Krause, Michael Lassmann and Caroline Stokke
    Journal of Nuclear Medicine May 22, 2025, jnumed.124.269378; DOI: https://doi.org/10.2967/jnumed.124.269378
  • <sup>177</sup>Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
    You have access
    177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
    Swayamjeet Satapathy, Chandan K. Das, Shikha Goyal, Ashwani Sood, Kannan Periasamy, Piyush Aggarwal, Komal Preet, Shrawan K. Singh, Ravimohan S. Mavuduru, Girdhar S. Bora, Aditya P. Sharma, Gaurav Prakash, Rajender Kumar, Harmandeep Singh and Bhagwant R. Mittal
    Journal of Nuclear Medicine May 22, 2025, jnumed.125.269913; DOI: https://doi.org/10.2967/jnumed.125.269913
View more published ahead of print articles

Featured Articles

  • CD70-Targeted [18F]RCCB6 Immuno-PET/CT Imaging in Patients with Nasopharyngeal Carcinoma...
    June 02, 2025
  • Targeting Extra Domain A of Fibronectin to Improve Noninvasive Detection of Triple-Negative Breast...
    June 02, 2025
  • Funding Reductions Threaten the Future of Medical Innovation
    June 02, 2025
  • The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical...
    June 02, 2025
  • Approaches to Imaging Immune Activation Using PET
    June 02, 2025
  • Diagnostic Radiopharmaceutical Trial Design: Is It Time to Change Nomenclature?
    June 02, 2025
  • From Genome to Phenome: Opportunities and Challenges of Molecular Imaging
    June 02, 2025
  • 2024 SNMMI Highlights Lecture: Cardiovascular Sciences
    June 02, 2025
  • FDA Approval of 18F-Flurpiridaz for PET: Stepping into a New Era of Myocardial Perfusion...
    June 02, 2025

About The Journal of Nuclear Medicine

The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research.

Current issue

Journal of Nuclear Medicine: 66 (6)
Journal of Nuclear Medicine
Vol. 66, Issue 6
June 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • CD70-Targeted [18F]RCCB6 Immuno-PET/CT Imaging in Patients with Nasopharyngeal Carcinoma: A Proof-of-Concept Study
  • Targeting Extra Domain A of Fibronectin to Improve Noninvasive Detection of Triple-Negative Breast Cancer
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
Back to top
SNMMI

© 2025 SNMMI

Powered by HighWire